VISTAGEN THERAPEUTICS, INC. (VTGN) Capital expenditures 2016–2022
VISTAGEN THERAPEUTICS, INC. (VTGN) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$200,400FY2022 · since FY2016: $26,300 → $200,400
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | $200,400 | -27.2% |
| FY2021 | $275,400 | — |
| FY2020 | $0 | -100.0% |
| FY2019 | $174,000 | +10775.0% |
| FY2018 | $1,600 | -99.3% |
| FY2017 | $239,100 | +809.1% |
| FY2016 | $26,300 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice